This program, when participated in its entirety, is available for 4 continuing education credits.  Division 39 is approved by the American Psychological Association to sponsor continuing education for psychologists.  Division 39 maintains responsibility for this program and its content. This presentation also meets the requirements of WAC 246-809-620 (definition of recognized categories of continuing education for licensed mental health counselors, marriage and family therapists and social workers).

PLEASE NOTE: THIS PROGRAM WILL NOT BE RECORDED FOR LATER VIEWING.

In this seminar, we will learn about the major psychedelic agents being used and researched for use with mental health issues. We will explore the powerful links between psychedelics and psychoanalysis, including opening and working with the unconscious, non-ordinary states, and transference and countertransference. We will also discuss what analysts need to know about talking with patients interested in psychedelics, so participants can leave feeling well-informed and able to navigate this cutting-edge terrain.

Presenter: 

Megan Rundel, Ph.D. is a psychoanalyst, psychedelic therapist, and Zen teacher in Oakland, CA. She is a Personal and Supervising Analyst at the Psychoanalytic Institute of Northern California, where she is also on the faculty. Additionally, she has a certificate in Psychedelic-Assisted Therapies and Research from CIIS, and has completed several advanced training programs in ketamine and psychedelic therapy. Her most recent paper is Psychedelic Psychoanalysis: Transformations of the Self, published in Psychoanalytic Dialogues in 2022. 

Learning Objectives:

After taking this course, participants will be able to:

• List the major psychedelic agents currently being used or researched for their efficacy in treating mental health issues, and their effects, methods of actions, contraindications, and research findings so far.
• Describe some of the transference and countertransference paradigms and issues that are common in clinical work with psychedelic agents.
• Explain how analysts can work in a skillful and knowledgeable way with patients who are interested in working with psychedelics or who are currently using them in a skillful and knowledgeable way.
• Discuss what analysts need to know to work effectively with non-ordinary states and their integration into everyday life, including containment, attunement, and negative capability.

Participants: This event is designed for graduate level students in mental health and all mental health professionals from introductory to advanced levels. 

Cost: $150 for Alliance members/$200 for non-Alliance members

Refund Policy: Refunds less a $35 handling fee will be given up until three weeks before the presentation. 

This program, when participated in its entirety, is available for 4.0 continuing education credits.  Division 39 is committed to accessibility and non-discrimination in its continuing education activities.  Division 39 is also committed to conducting all activities in conformity with the American Psychological Association's Ethical Principles for Psychologists.  Participants are asked to be aware of the need for privacy and confidentiality throughout the program.  If program content becomes stressful, participants are encouraged to process these feelings during discussion periods. If participants have special needs, we will attempt to accommodate them. Please address questions, concerns and any complaints to Erin Wright at eewright34@gmail.com.  There is no commercial support for this program nor are there any relationships between the CE Sponsor, presenting organization, presenter, program content, research, grants or other funding that could reasonably be construed as conflicts of interest.  Participants will be informed of the utility/validity of the content/approach discussed (including the basis for the statements about validity/utility), as well as the limitations of the approach and most common (and severe) risks, if any, associated with the program's content.